[20] The Application of Tissue Microarrays in the Validation of Microarray Results

Methods in Enzymology

Volumn 410, Issue , 2006, Pages 400-415

  Hewitt, Stephen M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL PROCEDURES; DATA ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MEDICAL RESEARCH; PRIORITY JOURNAL; PROTEOMICS; REVIEW; TISSUE MICROARRAY; VALIDATION STUDY; ANIMAL; DNA MICROARRAY; METHODOLOGY;

ANIMALS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TISSUE ARRAY ANALYSIS;

EID: 33747870205     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)10020-8     Document Type: Review

References (26)

1. Arney K.L. H19 and Igf2: Enhancing the confusion?. Trends Genet. 19 (2003) 17-23
2. Battifora H. The multitumor (sausage) tissue block: Novel method for immunohistochemical antibody testing. Lab. Invest. 55 (1986) 244-248
3. Braunschweig T., Chung J.-Y., and Hewitt S.M. Tissue microarrays: Bridging the gap between research and the clinic. Exp. Rev. Prot. 2 (2005) 325-336
4. Camp R.L., Chung G.G., and Rimm D.L. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat. Med. 8 (2002) 1323-1327
5. Fejzo M.S., and Slamon D.J. Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins. Am. J. Pathol. 159 (2001) 1645-1650
6. Fergenbaum J.H., Garcia-Closas M., Hewitt S.M., Lissowska J., Sakoda L.C., and Sherman M.E. Loss of antigenicity in stored sections of breast cancer tissue microarrays. Cancer Epidemiol. Biomark. Prev. 13 (2004) 667-672
7. Fernandez D.C., Bhargava R., Hewitt S.M., and Levin I.W. Infrared spectroscopic imaging for histopathologic recognition. Nat. Biotechnol. 23 (2005) 469-474
8. Geiszt M., Lekstrom K., Brenner S., Hewitt S.M., Dana R., Malech H.L., and Leto T.L. NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes. J. Immunol. 171 (2003) 299-306
9. Gillespie J.W., Best C.J., Bichsel V.E., Cole K.A., Greenhut S.F., Hewitt S.M., Ahram M., Gathright Y.B., Merino M.J., Strausberg R.L., Epstein J.I., Hamilton S.R., Gannot G., Baibakova G.V., Calvert V.S., Flaig M.J., Chuaqui R.F., Herring J.C., Pfeifer J., Petricoin E.F., Linehan W.M., Duray P.H., Bova G.S., and Emmert-Buck M.R. Evaluation of non-formalin tissue fixation for molecular profiling studies. Am. J. Pathol. 160 (2002) 449-457
10. Goodman M.T., Hernandez B.Y., Hewitt S., Lynch C.F., Cote T.R., Frierson Jr. H.F., Moskaluk C.A., Killeen J.L., Cozen W., Key C.R., Clegg L., Reichman M., Hankey B.F., and Edwards B. Tissues from population-based cancer registries: A novel approach to increasing research potential. Hum. Pathol. 36 (2005) 812-820
11. Harper M.E., Ullrich A., and Saunders G.F. Localization of the human insulin gene to the distal end of the short arm of chromosome 11. Proc. Natl. Acad. Sci. USA 78 (1981) 4458-4460
12. Hewitt S.M. Design, construction, and use of tissue microarrays. Methods Mol. Biol. 264 (2004) 61-72
13. Hewitt S.M., Dear J., and Star R.A. Discovery of protein biomarkers for renal diseases. J. Am. Soc. Nephrol. 15 (2004) 1677-1689
14. Hidalgo A., Pina P., Guerrero G., Lazos M., and Salcedo M. A simple method for the construction of small format tissue arrays. J. Clin. Pathol. 56 (2003) 144-146
15. Huang H.E., Chin S.F., Ginestier C., Bardou V.J., Adelaide J., Iyer N.G., Garcia M.J., Pole J.C., Callagy G.M., Hewitt S.M., Gullick W.J., Jacquemier J., Caldas C., Chaffanet M., Birnbaum D., and Edwards P.A. A recurrent chromosome breakpoint in breast cancer at the RG1/neuregulin 1/heregulin gene. Cancer Res. 64 (2004) 6840-6844
16. Khanna C., Prehn J., Hayden D., Cassaday R.D., Caylor J., Jacob S., Bose S.M., Hong S.H., Hewitt S.M., and Helman L.J. A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: Evaluation of insulin-like growth factor suppression and chemotherapy. Clin. Cancer Res. 8 (2002) 2406-2412
17. Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M.J., Sauter G., and Kallioniemi O.P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4 (1998) 844-847
18. LeBaron M.J., Crismon H.R., Utama F.E., Neilson L.M., Sultan A.S., Johnson K.J., Andersson E.C., and Rui H. Ultrahigh density microarrays of solid samples. Nat. Methods 2 (2005) 511-513
19. MacBeath G. Protein microarrays and proteomics. Nat. Genet. 32 Suppl. (2002) 526-532
20. Moskaluk C.A., and Stoler M.H. Agarose mold embedding of cultured cells for tissue microarrays. Diagn. Mol. Pathol. 11 (2002) 234-238
21. Nishizuka S., Chen S.T., Gwadry F.G., Alexander J., Major S.M., Scherf U., Reinhold W.C., Waltham M., Charboneau L., Young L., Bussey K.J., Kim S., Lababidi S., Lee J.K., Pittaluga S., Scudiero D.A., Sausville E.A., Munson P.J., Petricoin III E.F., Liotta L.A., Hewitt S.M., Raffeld M., and Weinstein J.N. Diagnostic markers that distinguish colon and ovarian adenocarcinomas: Identification by genomic, proteomic, and tissue array profiling. Cancer Res. 63 (2003) 5243-5250
22. Simon R., Nocito A., Hubscher T., Bucher C., Torhorst J., Schraml P., Bubendorf L., Mihatsch M.M., Moch H., Wilber K., Schotzau A., Kononen J., and Sauter G. Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. J. Natl. Cancer Inst. 93 (2001) 1141-1146
23. Su H., Hu N., Shih J., Hu Y., Wang Q.H., Chuang E.Y., Roth M.J., Wang C., Goldstein A.M., Ding T., Dawsey S.M., Giffen C., Emmert-Buck M.R., and Taylor P.R. Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res. 63 (2003) 3872-3876
24. Tan A.R., Yang X., Hewitt S.M., Berman A., Lepper E.R., Sparreboom A., Parr A.L., Figg W.D., Chow C., Steinberg S.M., Bacharach S.L., Whatley M., Carrasquillo J.A., Brahim J.S., Ettenberg S.A., Lipkowitz S., and Swain S.M. Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor. J. Clin. Oncol. 22 (2004) 3080-3090
25. In: Taylor C.R., and Cote R.J. (Eds). "Immnomicroscopy,". 3rd Ed. (2005), Saunders, Philadephia
26. Yang H., Wanner I.B., Roper S.D., and Chaudhari N. An optimized method for in situ hybridization with signal amplification that allows detection of rare mRNAs. J. Histochem. Cytochem. 47 (1999) 431-445